Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lotilaner Ophthalmic Solution for Demodex Blepharitis
CTR20220726Phase 3Completed
- Sponsor
- LianBio
- Start
- Apr 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lotilaner in Demodex blepharitis (DB), sponsored by LianBio. Started Apr 2022; status: completed.
02
Drugs
lotilaner
03
Conditions
Demodex blepharitis (DB)
Beyond the preview
Go deeper on CTR20220726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220726.